Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC

NCT06125041 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Extensive Small Cell Lung Cancer

Interventions

DRUG: Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy

Sponsor

Qianfoshan Hospital